NCT02013362View on ClinicalTrials.gov

Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

September 30, 2017

Conditions
Peripheral T-cell Lymphoma
Interventions
DRUG

Pralatrexate injection

DIETARY_SUPPLEMENT

Vitamin B12

DIETARY_SUPPLEMENT

Folic Acid

Trial Locations (3)

460-0001

National Hospital Organization Nagoya Medical Center, Nagoya

104-0045

National Cancer Center Hospital, Chūō

700-8558

Okayama University Hospital, Okayama

Sponsors

Lead Sponsor

Mundipharma K.K.
All Listed Sponsors
lead

Mundipharma K.K.

INDUSTRY